Doc menu

3. Commercial considerations

There have been instances brought to the attention of the SCoR where there have been proposals to charge for determining the fetal sex and/or performing a 3D/4D extension to scans requested under NHS provision. These proposals are often linked to the 18w to 20w 6d fetal anomaly scan. 

The SCoR is of the view that to charge to determine fetal sex and to add other commercial considerations into the NHS obstetric screening scans (beyond the already long established provision or sale of images discussed above) is inappropriate. These scans have a serious clinical purpose which is to screen for and to diagnose fetal abnormality if present, with the mother’s informed consent. Other scans requested during pregnancy within the NHS provision should only be for diagnostic or monitoring purposes related to specific maternal or fetal conditions.4

Accordingly, the SCoR does not support the commercialisation of scans that are being funded by the NHS for screening, diagnosis or monitoring. Reference should also be made to the British Medical Ultrasound Society safety guidelines which can be found at

Content tools

Accessibility controls

Text size